10/06/2022
Probiotics Chronic Kidney Disease patients
Clinical Trial To Evaluate Safety And Efficacy Of new probiotics which is in developmental phase for Subjects With Chronic Kidney Disease Stage IV. This new probiotic is not yet approved by FDA and hence not available in the market at this point of time.
See if you qualify: -
• If you age 18–80 years.
• Have chronic kidney disease stage IV (eGFR = 15 - 29 mL/min) with declining kidney function for a period > 6 months.
• Your blood Serum Creatinine > 2.0 mg/mL.
• You are not on probiotic supplements in the past 3 months.
• You are not on Immunosuppressant medications therapy specific to immune mediated renal diseases.
Above list includes few basic criteria’s and it is not a complete list of inclusion/ exclusion criteria.
Complete list of criteria’s will be checked after you meet few initial basic criteria’s
If you fully qualify to enrol in this trial, you will receive free study medication, free study specific lab work and compensation for your time to travel for this trial.